The U.S. Agency for International Development (USAID) HIV and AIDS program’s 15-year partnership with the International AIDS Vaccine Initiative (IAVI) began with a directive to USAID from the U.S. Congress. This shared endeavor works to ensure the development of safe, effective, accessible, preventive HIV vaccines for use throughout the world while strengthening clinical research capacity in regions most devastated by the epidemic. USAID, on the forefront of the global AIDS crisis for more than 30 years and a key implementing agency of the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), invests in the science that will deliver results and translate them from research to practice for populations at risk. Like many other authorities, USAID and IAVI believe the most critically important tool to control the HIV epidemic will be a safe and effective HIV vaccine. USAID is proud to highlight IAVI and partner accomplishments by emphasizing their role in supporting elegant science and meaningful research capacity throughout Africa, with the support of the American people.

To read more about this critical partnership and its accomplishments over the last 15 years, read the retrospective brief, Imagine a World without AIDS [PDF, 672KB].